Updates in Hematology CARE™ has been busy! See below the recent work from the CARE™ Hematology Faculty, featuring Discussion Video Series & Guidances. CARE™ CLL Case Study Series - Issue...

const evplayerplyr617654e72cd62 = new Plyr(document.getElementById('plyr617654e72cd62')); evplayerplyr617654e72cd62.ratio = '16:9'; Introduction This is a continuation of the case study presented in the 4th issue of the CARE™ CLL Case Series: Successful Initiation...

Introduction Welcome to the first issue in the CARE™ CLL Discussion series. CARE™ Hematology Faculty members, Dr. John Kuruvilla (Princess Margaret Cancer) and Peter Anglin (Stronach Reginal Cancer Centre) hosted...

Updates in Gastroenterology CARE™ has been busy! See below the recent work from the CARE™ Gastroenterology Faculty, featuring conference reporting and needs assessments. CARE™ Perspectives Report: DDW/ECCO 2021 The 2021...

Updates in Rheumatology CARE™ has been busy! See below the recent work from the CARE™ Rheumatology Faculty, featuring conference reporting, needs assessment results, and an active needs assessment. Needs Assessment...

Le rapport en ligne (en Français) Introduction The aim of this guidance is to provide education on(chimeric antigen receptor T-cell therapy (CAR T) options and considerations for effective integration of...

Introduction The annual EULAR conference updates scientific developments in rheumatology and dermatology. This report will focus on: Impact of novel agents on approaches to treating inflammatory arthritis. Parting comments consider:...

Introduction The 5th Annual CARE™ National Congress is an annual meeting bringing together representatives from the various CARE™ faculties, government and public and private payers to discuss biosimilar adoption and...

Introduction The 2021 virtual DDW and ECCO meetings both showcased exciting research that will advance the management of inflammatory bowel disease (IBD) in Canada. This CARE™ report highlights key news...

Introduction The annual EULAR conference updates scientific developments in rheumatology. This report will focus on: Impact of novel agents on approaches to treating inflammatory arthritis. Parting comments consider: Challenges related...